AUSTIN, TX – July 27, 2021 – pH Partners is pleased to announce the launch of an affiliate company, pH Blueprint. pH Blueprint is a strategic advisory practice focused on early and late-stage startups and well established companies with a mindset for growth. The pH Blueprint seasoned executives serve six healthcare verticals – Care Delivery, Therapeutics, Diagnostics, Consumer Health, Medical Devices, and Digital Health.
pH Blueprint, with professionals in Austin, Houston, Boston, and Manhattan, delivers real world insights and guidance. “Too many promising early-stage companies fail because of a lack of product-market fit or poor business model. Many large companies do not have line of sight on the innovations coming out of the start-up ecosystem. We have an amazing team of entrepreneurial healthcare and life science executives who can leverage their experience and networks to the benefit of all of our clients regardless of size or stage” said Erik Halvorsen, Partner at pH Blueprint.
pH Blueprint delivering value today:
Public Oncology Diagnostics Client- pH Blueprint engaged with a publicly traded oncology diagnostic company with a large appetite to grow their commercial presence internationally through an active partnering and licensing strategy. The pH Blueprint team actively drives client development and product management by meeting milestone objectives and revenue goals for the organization through the placement of a seasoned executive with a strong success record. To date, all milestones and revenue goals have been met.
Private Women’s Health Client- pH Blueprint client has a mission focused on improving women’s health by creating a more cohesive patient experience. The pH Blueprint team has been engaged to structure a laboratory testing strategy that will ease access to testing and improve patient compliance for women at various stages of life. The patient experience is equally as important as the quality of the test and is being designed to engage, inform and over- deliver to the patient from test order and sample collection to test results.
“pH Blueprint is uniquely positioned to act as a trusted advisor to our growth focused clients,” said Rachel Ravens, Co-Founder and Managing Partner of pH Blueprint. “Our team connects people and organizations across the healthcare and life science ecosystem to serve disease states and improve interoperability.” pH Blueprint is well positioned to offer expertise, insight, and guidance on product and pipeline strategy, regulatory and clinical, business development and revenue growth, pricing and reimbursement, licensing and strategic partnering to help bring our client’s growth objectives to reality.
About pH Partners | pH Partners is a boutique investment bank focused on providing M&A and capital raise advisory services to companies at the intersection of healthcare, technology and consumer products. pH leverages relationships with leading pharmaceutical, medical technology and diagnostic companies to create strategic opportunities for its client base of emerging companies that are improving care and lowering costs in the healthcare sector. Our leadership has over 50 years of combined experience advising clients on strategic and capital raising transactions.
About pH Blueprint | pH Blueprint is a strategic advisory firm focused on helping clients find uncommon growth by pairing them with experienced leaders who have led successful companies, R&D programs, launched products, acquired assets, and maximized exit valuations. pH leverages relationships with leading pharmaceutical, medical technology and diagnostic companies to create strategic opportunities for its client base of emerging companies that are improving care and lowering costs in the healthcare sector. We operate differently than other consultancies by blending insight, strategy and experience with an optimistic yet practical approach. The work we deliver challenges us stay curious. We’re all about vision and growth: For our clients, for our people and for healthcare.
The information contained in this press release is correct at the time of going to press. For more information, please visit www.phblueprint.com.